The tropism of the recombinants was evaluated in the HER2-positive SK-OV-3 cancer cells, in the Vero-GCN4R, in wt Vero cells, and in derivatives of the receptor-negative J cells, transgenically expressing a single receptor, e.g., HER2, nectin1, or HVEM (20, 36). Here, TNFRSF14 is linked to cancer.